Why the study?
Does Rac1 inhibition prevent doxorubicin-induced cardiotoxicity in preclinical models?
Population
Mouse model of acute doxorubicin-induced cardiotoxicity, rat cardiomyoblasts, and cultured neonatal mouse…
Comparison
Cardiomyocyte-specific deletion of Rac1… vs Control (wild-type mice or untreated cells)
Design
Preclinical
Authors
Loading...
Rac1 inhibition attenuates doxorubicin cardiotoxicity in mice; leaves open translation to human cardioprotection.
Does Rac1 inhibition prevent doxorubicin-induced cardiotoxicity in preclinical models?
Rac1 inhibition protects against doxorubicin-induced cardiotoxicity via both ROS-dependent and ROS-independent (HDAC/p53) pathways, suggesting a potential therapeutic target.
Ma et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: